Pathology of bladder cancer among diabetic patients undergoing radical cystectomy with a history of pioglitazone (Actos) use

@inproceedings{Romero2014PathologyOB,
  title={Pathology of bladder cancer among diabetic patients undergoing radical cystectomy with a history of pioglitazone (Actos) use},
  author={Victoriano Cortijo Romero and Charles C. Peyton and Ian Gray and Ashok K Hemal and Ryan P Terlecki},
  booktitle={BMC Urology},
  year={2014}
}
BackgroundProspective studies suggested an association between pioglitazone (Actos) use and the development of bladder cancer. Cancer pathology among pioglitazone users has not been characterized. We chose to compare the surgical pathology among diabetic users and non-users, as well as non-diabetic patients who underwent radical cystectomy for bladder cancer.MethodsOur single-center, prospectively-maintained bladder cancer database was reviewed. Patient demographics, surgical pathology, and… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 13 REFERENCES

[Pioglitazone and the risk of bladder cancer].

  • Nihon rinsho. Japanese journal of clinical medicine
  • 2016
VIEW 1 EXCERPT

Actos (Pioglitazone Hydrochloride) Full Prescribing Information

I Takeda Pharmaceuticals America
  • http://www.takeda.us/products, November,
  • 2012
VIEW 3 EXCERPTS

Effects of PPARgamma and combined agonists on the urinary tract of rats and other species.

  • Toxicological sciences : an official journal of the Society of Toxicology
  • 2005
VIEW 1 EXCERPT

Thiazolidinediones

H Yki-Jarvinen
  • N Engl J Med
  • 2004